SCHEMBL20630750

SCHEMBL20630750

COc1ccc(-c2ccc(C(=O)NCCOCCOc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLH Q9Y253 6/20 0.61
▸ KDM4E B2RXH2 3/20 0.57
▸ RECQL P46063 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ MAPT P10636 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ APEX1 P27695 2/20 0.57
▸ MMP1 P03956 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ CYP3A4 P08684 3/20 0.55
▸ CYP2D6 P10635 2/20 0.55
▸ PLG P00747 1/20 0.54
▸ NOX4 Q9NPH5 1/20 0.54
▸ SRC P12931 1/20 0.50
▸ EPHX2 P34913 1/20 0.49
▸ TUBB4A P04350 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20630799 0.94 POLH (0.66) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20631332 0.93 POLH (0.62) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20631304 0.91 POLH (0.62) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20630770 0.90 POLH (0.67) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20630208 0.88 POLH (0.65) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20630949 0.86 POLH (0.68) POLHKDM4ERECQLMEN1MAPT
SCHEMBL24497194 0.83 POLH (0.72) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20631318 0.82 POLH (0.67) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20630205 0.82 POLH (0.56) POLHKDM4ERECQLMEN1MAPT
SCHEMBL20630753 0.81 POLH (0.64) POLHKDM4ERECQLMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022118186-A1 SENOTHERAPEUTIC COMPOUND BIONEXA S.R.L. (IT) 2022-06-09 — — WO disclosed
US-20200323814-A1 MEDICAL COMPOUND VERA SALUS RICERCA S.R.L. (IT) 2020-10-15 — — US disclosed
WO-2019008537-A9 MEDICAL COMPOUNDS VERA SALUS RICERCA S.R.L. (IT) 2020-02-20 — — WO disclosed
WO-2019008537-A1 MEDICAL COMPOUNDS VERA SALUS RICERCA S.R.L. (IT) 2019-01-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200323814-A1 MEDICAL COMPOUND MTNR1B, CBR1, MTNR1A POLH 3942/4885KDM4E 3339/4885RECQL 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback